263 related articles for article (PubMed ID: 34804443)
1. Pediatric Mastocytosis: An Update.
Giona F
Mediterr J Hematol Infect Dis; 2021; 13(1):e2021069. PubMed ID: 34804443
[TBL] [Abstract][Full Text] [Related]
2. Molecular Background, Clinical Features and Management of Pediatric Mastocytosis: Status 2021.
Lange M; Hartmann K; Carter MC; Siebenhaar F; Alvarez-Twose I; Torrado I; Brockow K; Renke J; Irga-Jaworska N; Plata-Nazar K; Ługowska-Umer H; Czarny J; Belloni Fortina A; Caroppo F; Nowicki RJ; Nedoszytko B; Niedoszytko M; Valent P
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33806685
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic criteria and classification of mastocytosis: a consensus proposal.
Valent P; Horny HP; Escribano L; Longley BJ; Li CY; Schwartz LB; Marone G; Nuñez R; Akin C; Sotlar K; Sperr WR; Wolff K; Brunning RD; Parwaresch RM; Austen KF; Lennert K; Metcalfe DD; Vardiman JW; Bennett JM
Leuk Res; 2001 Jul; 25(7):603-25. PubMed ID: 11377686
[TBL] [Abstract][Full Text] [Related]
4. Current Challenges in the Diagnosis of Pediatric Cutaneous Mastocytosis.
Ługowska-Umer H; Czarny J; Rydz A; Nowicki RJ; Lange M
Diagnostics (Basel); 2023 Dec; 13(23):. PubMed ID: 38066824
[TBL] [Abstract][Full Text] [Related]
5. Mastocytosis: state of the art.
Horny HP; Sotlar K; Valent P
Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
[TBL] [Abstract][Full Text] [Related]
6. Natural evolution in pediatric cutaneous mastocytosis: 10-year follow-up.
Czarny J; Renke J; Żawrocki A; Nowicki RJ; Lange M
Int J Dermatol; 2021 Oct; 60(10):1253-1257. PubMed ID: 33904158
[TBL] [Abstract][Full Text] [Related]
7. Challenges in the Diagnosis of Cutaneous Mastocytosis.
Brockow K; Bent RK; Schneider S; Spies S; Kranen K; Hindelang B; Kurgyis Z; Broesby-Olsen S; Biedermann T; Grattan CE
Diagnostics (Basel); 2024 Jan; 14(2):. PubMed ID: 38248039
[TBL] [Abstract][Full Text] [Related]
8. Large maculopapular cutaneous lesions are associated with favorable outcome in childhood-onset mastocytosis.
Wiechers T; Rabenhorst A; Schick T; Preussner LM; Förster A; Valent P; Horny HP; Sotlar K; Hartmann K
J Allergy Clin Immunol; 2015 Dec; 136(6):1581-1590.e3. PubMed ID: 26152315
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous mastocytosis in childhood.
Nemat K; Abraham S
Allergol Select; 2022; 6():1-10. PubMed ID: 35028497
[TBL] [Abstract][Full Text] [Related]
10. Histopathological characteristics are instrumental to distinguish monomorphic from polymorphic maculopapular cutaneous mastocytosis in children.
Hermans MAW; Pasmans SGMA; Arends NJT; van den Bosch TPP; van Daele PLA; van Doorn MBA; Huisman EJ; Mooyaart AL; Damman J
Clin Exp Dermatol; 2022 Sep; 47(9):1694-1702. PubMed ID: 35596520
[TBL] [Abstract][Full Text] [Related]
11. Solitary mastocytoma presenting in an adult: report and literature review of adult-onset solitary cutaneous mastocytoma with recommendations for evaluation and treatment.
Cohen PR
Dermatol Pract Concept; 2016 Jul; 6(3):31-8. PubMed ID: 27648381
[TBL] [Abstract][Full Text] [Related]
12. Mastocytosis: from a Molecular Point of View.
Komi DEA; Rambasek T; Wöhrl S
Clin Rev Allergy Immunol; 2018 Jun; 54(3):397-411. PubMed ID: 28725969
[TBL] [Abstract][Full Text] [Related]
13. Mastocytosis in children: a single-center long-term follow-up study.
Popadic S; Lalosevic J; Lekic B; Gajić-Veljic M; Bonaci-Nikolic B; Nikolic M
Int J Dermatol; 2023 May; 62(5):616-620. PubMed ID: 36807903
[TBL] [Abstract][Full Text] [Related]
14. [Mastocytosis in children].
Wassmer H; Hartmann K
Dermatologie (Heidelb); 2023 May; 74(5):323-329. PubMed ID: 37140636
[TBL] [Abstract][Full Text] [Related]
15. [Mastocytosis, classification, biological diagnosis and therapy].
Arock M
Ann Biol Clin (Paris); 2004; 62(6):657-69. PubMed ID: 15563424
[TBL] [Abstract][Full Text] [Related]
16. Mediator-Related Symptoms and Anaphylaxis in Children with Mastocytosis.
Brockow K; Plata-Nazar K; Lange M; Nedoszytko B; Niedoszytko M; Valent P
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33799959
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous mastocytosis treatment: strategies, limitations and perspectives.
Czarny J; Lange M; Ługowska-Umer H; Nowicki RJ
Postepy Dermatol Alergol; 2018 Dec; 35(6):541-545. PubMed ID: 30618520
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis, classification and treatment of mastocytosis: state of the art in 2010 and future perspectives.
Arock M; Valent P
Expert Rev Hematol; 2010 Aug; 3(4):497-516. PubMed ID: 21083038
[TBL] [Abstract][Full Text] [Related]
19. [Therapeutically relevant mutations in the receptor tyrosine kinase KIT in mastocytosis].
Sotlar K
Verh Dtsch Ges Pathol; 2007; 91():169-76. PubMed ID: 18314612
[TBL] [Abstract][Full Text] [Related]
20. Criteria for the Regression of Pediatric Mastocytosis: A Long-Term Follow-Up.
Polivka L; Rossignol J; Neuraz A; Condé D; Agopian J; Méni C; Garcelon N; Dubreuil P; Maouche-Chrétien L; Hadj-Rabia S; Hermine O; Bodemer C
J Allergy Clin Immunol Pract; 2021 Apr; 9(4):1695-1704.e5. PubMed ID: 33338682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
